Wednesday 30 Oct 2024
By
main news image

SINGAPORE (May 9): With Raffles Medical Group trading ex-entitlement for its one-to-three share split today (9 May), OCBC Investment research has adjusted its fair-value estimate to $1.57 while maintaining its “hold” rating.

The broker had downgraded the stock from a “buy” post-1Q16 results due to limited upside.

It adds that it still likes the group’s long term plans of expanding capacity as well as geographical presence. This year, RMG’s Holland Village mall is slated to be ready by June, which will house a range of their clinics. In 2017, it will expand its current hospital campus in Bugis. As for the Shanghai hospital, due to a long approval process in China, management now expects the hospital to be ready by Dec 31, 2018.

OCBC urges longer-term investors to look for buying opportunities at $1.45 or lower. 

      Print
      Text Size
      Share